ID

30825

Description

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00866060

Link

https://clinicaltrials.gov/show/NCT00866060

Keywords

Versions (1)
  1. 6/24/18 6/24/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 24, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Moderate to Severe Alzheimer's Disease NCT00866060

English

Eligibility Moderate to Severe Alzheimer's Disease NCT00866060

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants will be patients who meet nincds-adrda criteria for probable or possible alzheimer's disease (mckhann et al, 1984). in addition they will meet all of the following criteria:
Description

Alzheimer's Disease Probable | Alzheimer's Disease Possible

Data type

boolean

Alias
UMLS CUI [1,1]
C0002395
UMLS CUI [1,2]
C0332148
UMLS CUI [2,1]
C0002395
UMLS CUI [2,2]
C0332149
1. smmse = 5 to 13 (13 chosen as nice threshold of 10 plus 1 sd on smmse score)
Description

Mini-mental state examination standardized

Data type

boolean

Alias
UMLS CUI [1,1]
C0451306
UMLS CUI [1,2]
C0237892
2. continuously prescribed donepezil for at least 3 months
Description

Donepezil

Data type

boolean

Alias
UMLS CUI [1]
C0527316
3. maintained on 10mg donepezil in previous 6 weeks.
Description

Donepezil Dosage

Data type

boolean

Alias
UMLS CUI [1,1]
C0527316
UMLS CUI [1,2]
C0178602
4. no changes in prescription of any psychotropic (antipsychotic, antidepressant, benzodiazepine) medication in previous 6 weeks.
Description

Psychotropic Drugs unchanged | Antipsychotic Agents | Antidepressive Agents | Benzodiazepines

Data type

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C0442739
UMLS CUI [2]
C0040615
UMLS CUI [3]
C0003289
UMLS CUI [4]
C0005064
5. prescribing clinician considers (based on nice guidance, discussions with patient and carer and clinical judgement) that change of drug treatment (i.e. stop donepezil or introduce memantine) may be appropriate.
Description

Pharmacotherapy Change considered | Donepezil To be stopped | Memantine Introduce

Data type

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C0750591
UMLS CUI [2,1]
C0527316
UMLS CUI [2,2]
C1272691
UMLS CUI [3,1]
C0025242
UMLS CUI [3,2]
C1292748
6. patient is community resident and has family or professional carer or is visited on at least a daily basis by carer.
Description

Lives in a community | Availability of Caregiver

Data type

boolean

Alias
UMLS CUI [1]
C0557143
UMLS CUI [2,1]
C0470187
UMLS CUI [2,2]
C0085537
7. patient agrees to participate if considered capable (see section 7.5)
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
8. main carer (informal or professional) consents to their own involvement and the patient's involvement -
Description

Informed Consent Caregiver

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0085537
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
to maximise the generalisability of the study data, exclusions will be kept to a minimum. these will include:
Description

Exclusion Criteria Minimum

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524031
1. patient has severe, unstable or poorly controlled medical conditions apparent from physical examination or clinical history.
Description

Medical condition Severe Physical Examination | Medical condition Unstable Physical Examination | Medical condition Poorly controlled Physical Examination | Medical condition Severe Medical History | Medical condition Unstable Medical History | Medical condition Poorly controlled Medical History

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0031809
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
UMLS CUI [2,3]
C0031809
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C3853134
UMLS CUI [3,3]
C0031809
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C0262926
UMLS CUI [5,1]
C3843040
UMLS CUI [5,2]
C0443343
UMLS CUI [5,3]
C0262926
UMLS CUI [6,1]
C3843040
UMLS CUI [6,2]
C3853134
UMLS CUI [6,3]
C0262926
2. patient is already prescribed memantine.
Description

Memantine prescribed

Data type

boolean

Alias
UMLS CUI [1,1]
C0025242
UMLS CUI [1,2]
C0278329
3. patient is unable to take trial medications because of contra-indications or previous adverse or allergic reactions.
Description

Medical contraindication Investigational New Drugs | Adverse reactions Investigational New Drugs | Allergic Reaction Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0559546
UMLS CUI [2,2]
C0013230
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C0013230
4. patient is involved in another clinical trial.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
5. clinician considers patient would not be compliant with trial medication. -
Description

Compliance behavior Absent Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0013230
Back to the top of the page

Similar models

Eligibility Moderate to Severe Alzheimer's Disease NCT00866060

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Alzheimer's Disease Probable | Alzheimer's Disease Possible
Item
participants will be patients who meet nincds-adrda criteria for probable or possible alzheimer's disease (mckhann et al, 1984). in addition they will meet all of the following criteria:
boolean
C0002395 (UMLS CUI [1,1])
C0332148 (UMLS CUI [1,2])
C0002395 (UMLS CUI [2,1])
C0332149 (UMLS CUI [2,2])
Mini-mental state examination standardized
Item
1. smmse = 5 to 13 (13 chosen as nice threshold of 10 plus 1 sd on smmse score)
boolean
C0451306 (UMLS CUI [1,1])
C0237892 (UMLS CUI [1,2])
Donepezil
Item
2. continuously prescribed donepezil for at least 3 months
boolean
C0527316 (UMLS CUI [1])
Donepezil Dosage
Item
3. maintained on 10mg donepezil in previous 6 weeks.
boolean
C0527316 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Psychotropic Drugs unchanged | Antipsychotic Agents | Antidepressive Agents | Benzodiazepines
Item
4. no changes in prescription of any psychotropic (antipsychotic, antidepressant, benzodiazepine) medication in previous 6 weeks.
boolean
C0033978 (UMLS CUI [1,1])
C0442739 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2])
C0003289 (UMLS CUI [3])
C0005064 (UMLS CUI [4])
Pharmacotherapy Change considered | Donepezil To be stopped | Memantine Introduce
Item
5. prescribing clinician considers (based on nice guidance, discussions with patient and carer and clinical judgement) that change of drug treatment (i.e. stop donepezil or introduce memantine) may be appropriate.
boolean
C0013216 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0750591 (UMLS CUI [1,3])
C0527316 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0025242 (UMLS CUI [3,1])
C1292748 (UMLS CUI [3,2])
Lives in a community | Availability of Caregiver
Item
6. patient is community resident and has family or professional carer or is visited on at least a daily basis by carer.
boolean
C0557143 (UMLS CUI [1])
C0470187 (UMLS CUI [2,1])
C0085537 (UMLS CUI [2,2])
Informed Consent
Item
7. patient agrees to participate if considered capable (see section 7.5)
boolean
C0021430 (UMLS CUI [1])
Informed Consent Caregiver
Item
8. main carer (informal or professional) consents to their own involvement and the patient's involvement -
boolean
C0021430 (UMLS CUI [1,1])
C0085537 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria Minimum
Item
to maximise the generalisability of the study data, exclusions will be kept to a minimum. these will include:
boolean
C0680251 (UMLS CUI [1,1])
C1524031 (UMLS CUI [1,2])
Medical condition Severe Physical Examination | Medical condition Unstable Physical Examination | Medical condition Poorly controlled Physical Examination | Medical condition Severe Medical History | Medical condition Unstable Medical History | Medical condition Poorly controlled Medical History
Item
1. patient has severe, unstable or poorly controlled medical conditions apparent from physical examination or clinical history.
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0031809 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C3853134 (UMLS CUI [3,2])
C0031809 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0262926 (UMLS CUI [4,3])
C3843040 (UMLS CUI [5,1])
C0443343 (UMLS CUI [5,2])
C0262926 (UMLS CUI [5,3])
C3843040 (UMLS CUI [6,1])
C3853134 (UMLS CUI [6,2])
C0262926 (UMLS CUI [6,3])
Memantine prescribed
Item
2. patient is already prescribed memantine.
boolean
C0025242 (UMLS CUI [1,1])
C0278329 (UMLS CUI [1,2])
Medical contraindication Investigational New Drugs | Adverse reactions Investigational New Drugs | Allergic Reaction Investigational New Drugs
Item
3. patient is unable to take trial medications because of contra-indications or previous adverse or allergic reactions.
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0559546 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3,1])
C0013230 (UMLS CUI [3,2])
Study Subject Participation Status
Item
4. patient is involved in another clinical trial.
boolean
C2348568 (UMLS CUI [1])
Compliance behavior Absent Investigational New Drugs
Item
5. clinician considers patient would not be compliant with trial medication. -
boolean
C1321605 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial